This inventor holds 1 USPTO granted patent. Top assignee: Cancer Research Campaign Technology Limited. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Richard Henry Begent: Innovator in Cancer Research
Introduction
Richard Henry Begent is a notable inventor based in London, GB. He has made significant contributions to the field of cancer research, particularly through his innovative work on antibodies.
Latest Patents
Richard holds a patent for an antibody against carcinoembryonic antigen (CEA). This invention is crucial in the ongoing battle against cancer, providing new avenues for diagnosis and treatment.
Career Highlights
Richard is associated with Cancer Research Campaign Technology Limited, where he applies his expertise to advance cancer research. His work has been instrumental in developing new therapeutic strategies.
Collaborations
Richard has collaborated with esteemed colleagues, including Robert E Hawkins and Kerry Anne Chester. These partnerships have enhanced the impact of his research and innovations.
Conclusion
Richard Henry Begent's contributions to cancer research through his patent and collaborations highlight his commitment to improving patient outcomes. His work continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile